Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026.
Zacks Investment Research on MSN
Novo Nordisk vs. Amgen: Which healthcare stock is the smarter choice?
Both Novo Nordisk NVO and Amgen AMGN are large-cap, innovation-driven healthcare leaders with global scale, strong balance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback